|
NRS77
|
NCTC 8325; RN1 |
Staphylococcus aureus |
Standard lab strain; propagating strain for typing phage 47; virulence factor staphylokinase. |
|
|
NRS133
|
NCTC8325 (RN0025) |
Staphylococcus aureus |
RN0001, UV cured of Φ11 and Φ12. all NCTC 8325 derivatives are agr group I. |
|
|
NRS134
|
NCTC8325 (RN0027) |
Staphylococcus aureus |
RN0025, lysogenized with 80α |
|
|
NRS135
|
NCTC8325 (RN0450) |
Staphylococcus aureus |
RN0001 UV cured of Φ11, Φ12, and Φ13; partially agr-defective |
|
|
NRS136
|
NCTC8325 (RN0451) |
Staphylococcus aureus |
RN0450 re-lysogenized with Φ11 |
|
|
NRS137
|
NCTC8325 (RN0453) |
Staphylococcus aureus |
standard donor of Tn551 from pI258 mutant thermosensitive for replication |
|
|
NRS138
|
RN0833 |
Staphylococcus warneri |
Naturally occurring producer of the agrD autoinducing peptide, YINCTNFF, which is an agr inhibitor for all four agr groups in S. aureus. |
|
|
NRS139
|
NCTC8325 (RN0981) |
Staphylococcus aureus |
Heavily mutagenized derivative of RN450 with multiple defects. |
|
|
NRS140
|
NCTC8325 (RN1389) |
Staphylococcus aureus |
Tn554 is a site-specific, high frequency transposon encoding erythromycin and spectinomycin resistances. |
|
|
NRS141
|
NCTC8325 (RN3214) |
Staphylococcus aureus |
pUB110 is a naturally-occuring Skb rolling circle plasmid encoding resistances to aminoglycosides (neomycin & kanamycin) and to bleomycin. It belongs to the pc194 family. It replicates more efficiently in Bacillus subtilis than in S. aureus. |
|
|
NRS142
|
NCTC8325 (RN3763) |
Staphylococcus aureus |
pSA0341 has a repC mutation causing thermosensitive plasmid replication, isolated by S.Iordanesco. |
|
|
NRS143
|
NCTC8325 (RN3984) |
Staphylococcus aureus |
SaPI2 is a phase-related pathogenicity island ~10kb; transduction at high frequency by phage 80. |
|
|
NRS144
|
NCTC8325 (RN4220) |
Staphylococcus aureus |
RN4220 was selected for transformability with DNA from E. coli. It has a partial agr defect. |
|
|
NRS145
|
RN4282 |
Staphylococcus aureus |
SaPI1 is a mobile 15-kb pathogenicity island transduced at high frequency by phage 80α. RN4282 is the strain from which tst was first cloned. |
|
|
NRS146
|
NCTC8325 (RN5843) |
Staphylococcus aureus |
pRN6441 is a derivative of pE194, a 3.8 kb rolling circle plasmid, with a mutation in repF causing thermosesitive replication, plus the insertion of the puC19 multiple cloning site in its single PstI site. |
|
|
NRS147
|
NCTC8325 (RN6390B) |
Staphylococcus aureus |
RN6390 is the strain from which the agr locus was first cloned. It is the agr group I prototype. RN6390 frequently gives rise to agr-negative mutants. RN6390B is an agr-positive re-isolate from an RN6390 stock culture that had become mostly agr-negative. |
|
|
NRS148
|
RN6432 ;"Smith diffuse" |
Staphylococcus aureus |
Heavily encapsulated; undergoes phase variation to generate capsule-variants that form compact colonies in serum 0.3% agar and is known as "Smith compact". |
|
|
NRS149
|
502A (RN6607) |
Staphylococcus aureus |
standard agr group II prototype; formerly used for bioprotection against 80/81 epidemic phage type. |
|
|
NRS150
|
NCTC8325 (RN6709) |
Staphylococcus aureus |
pRN5543 is a derivative of pC194 with the pUC19 multiple cloning site at the HindIII site, one HindIII site eliminated. |
|
|
NRS151
|
NCTC8325 (RN6911) |
Staphylococcus aureus |
agr locus in 8325-4 replaced by tetM; overproduces protein A. |
|
|
NRS152
|
WGB4316 (RN7044) |
Staphylococcus aureus |
pWBG32 is a small rolling circle of the pSN2 family encoding an efflux pump for quarternary amines. |
|
|
NRS153
|
RN8540 |
Staphylococcus aureus |
agr group IV prototype |
|
|
NRS154
|
RN4850 (RN9121) |
Staphylococcus aureus |
agr-null derivative of agr group IV prototype |
|
|
NRS155
|
502A (RN9120) |
Staphylococcus aureus |
agr-null derivative of 502A, agr-group II prototype. |
|
|
NRS281
|
COLVA |
Staphylococcus aureus |
Vancomycin-resistant transconjugant |
|
|
NRS407
|
HIP12467 |
Enterococcus faecalis |
co-isolate of Michigan VRSA (VRS1) |
|
|
NRS408
|
HIP11713 |
Staphylococcus aureus |
Probable recipient of Tn1546 from Enterococcus faecalis to produce VRSA (VRS1) |
|
